RhumbLine Advisers’s Tyra Biosciences TYRA Stock Holding History
Bought
Maintained
Sold
Other funds holding TYRA
SL
RhumbLine Advisers's TYRA Position: Q3 2026 in Review
RhumbLine Advisers reduced its Tyra Biosciences (TYRA) stake by 3% in Q3 2026, selling an estimated $42.2K and leaving 50,503 shares worth $1.1M. The position accounts for ﹤0.01% of the portfolio, ranked #2208.
RhumbLine Advisers first reported a position in TYRA in Q1 2022 and has held it in 19 quarters since. The position peaked at $1.66M in Q2 2026. 99 funds tracked by Wall St. Rank hold TYRA as of Q3 2026.
- RhumbLine Advisers held 50,503 shares of Tyra Biosciences worth $1.1M as of Q3 2026.
- RhumbLine Advisers sold 1,536 Tyra Biosciences shares in Q3 2026, an estimated $42.2K.
- Tyra Biosciences made up ﹤0.01% of RhumbLine Advisers's portfolio in Q3 2026, its #2208 holding.
- RhumbLine Advisers first reported a position in Tyra Biosciences in Q1 2022 and has held it in 19 quarters since.
- RhumbLine Advisers's Tyra Biosciences position peaked at $1.66M in Q2 2026.
- 99 funds tracked by Wall St. Rank held Tyra Biosciences as of Q3 2026.
Based on RhumbLine Advisers's 13F filing for Q3 2026, filed 10 Nov 2026.